PacBio to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit

Rhea-AI Summary

PacBio (NASDAQ: PACB) announced its participation in the UBS Genomics 2.0 and MedTech Innovations Summit in Dana Point, California, on August 11, 2022. The company will host a fireside chat at 11:00 a.m. Pacific Time, which will be available via live webcast on their investors page. A replay will be accessible for 30 days post-event. PacBio specializes in advanced sequencing solutions, focusing on accuracy and quality across diverse applications, including oncology and infectious diseases. For more information, visit www.pacb.com.

Argus Session date unavailable

+4.30% session move Open Argus

Details

News Market Reaction – PACB

The recorded move for PACB in the trading session of this news was +4.30%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MENLO PARK, Calif., Aug. 5, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB) announced today that it will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations Summit in Dana Point, California.

PacBio's management is scheduled to participate in a fireside chat on Thursday, August 11 at 11:00 a.m. Pacific Time / 2:00 p.m. Eastern Time. The live webcast can be accessed at the company's investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for at least 30 days following the presentation.

About PacBio

Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems.  Our products and technology under development stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our existing HiFi long read sequencing and our emerging SBB™ short read sequencing technologies. Our products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.

Contacts

Investors: 
Todd Friedman
650.521.8450
ir@pacb.com 

Media:
Lizelda Lopez
pr@pacb.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/pacbio-to-participate-in-the-ubs-genomics-2-0-and-medtech-innovations-summit-301600619.html

SOURCE Pacific Biosciences of California, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is PacBio's fireside chat at the UBS Genomics 2.0 Summit?

PacBio's fireside chat is scheduled for August 11, 2022, at 11:00 a.m. Pacific Time.

How can I access PacBio's live webcast during the summit?

The live webcast can be accessed on PacBio's investor page at investor.pacificbiosciences.com.

What topics will PacBio cover at the UBS Genomics Summit?

PacBio will discuss its advanced sequencing solutions and technologies at the UBS Genomics Summit.

Where is the UBS Genomics 2.0 and MedTech Innovations Summit being held?

The summit is taking place in Dana Point, California.

What is the focus of PacBio's technology?

PacBio focuses on high accuracy and quality in sequencing technologies for various applications, including human germline sequencing and oncology.